Each year the Fundación de Investigación del Cáncer de la Universidad de la Salamanca (FICUS) - Centro de Investigación del Cáncer (CIC) presents the 'Doctores Diz Pintado' Prize with the aim to promote and acknowledge the contribution of young Spanish researchers to Cancer Research.
Nostrum Biodiscovery, a spin-off from IRB Barcelona and the BSC-CNS, focuses on computational simulation to design new drugs and biotech molecules for the market.
The Senén Vilaró Prize is given each year by the “Consejo Social” of the UB and the Bosch i Gimpera Foundation to the best innovative company.
When you hear the word ‘immunotherapy’, the first thing that comes to mind is that it is a highly effective treatment for cancer. But could it also be the solution or hope for other conditions?
This was precisely the subject addressed at the Barcelona Biomed Conference “Immunotherapy beyond cancer. A cure for age-related diseases”, an event organised by the Institute for Research in Biomedicine (IRB Barcelona) from 18 to 20 November that brought together more than 100 scientists.
Over 3 days, researchers from all over the world have emphasized the potential of this new therapy for other applications. In this regard, Manuel Serrano...
Organised by PhD students and postdocs, ENABLE is aimed at the community of young researchers working in biomedicine.
The 3rd ENABLE symposium was held in Nijmegen (the Netherlands) from 13 to 15 November.
The symposium was cofunded by the European Commission and is managed and organised by four research institutes (IRB Barcelona, RIMLS, NNF CPR, and SEMM) and a science communication agency (Scienseed).
The jury unanimously decided to award Salvador Aznar Benitah in acknowledgement of his work on adult stem cells and the relation of these with circadian rhythms and metastasis, and also in recognition of his recent entrepreneurial activity.
The award is given in recognition of biochemistry and molecular biology research of excellence performed mainly in Spain.
In 2017, Fran Supek started his research group at IRB Barcelona devoted to statistical genomics.
Through its Young Investigator Programme, EMBO identifies and supports some of the best young researchers in the life sciences.
The funded project will address the development of metastasis in breast cancer.
The grant, which is specifically for research into breast cancer, has been given by the foundation, in collaboration with Mango.
Fero is a private foundation that promotes translational cancer research in Spain.
The foundation will be funding 43 cancer research projects.
The Ministry of Science, Innovation and Universities, through the State Research Agency, has awarded the Institute for Research in Biomedicine (IRB Barcelona) €237,500 to carry out the project “Fostering IRB Barcelona internationalisation and H2020 participation” (IRBInterH)”, an action supported by the “Europa Redes y Gestores-Europa Centros Tecnológicos 2019” call (Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020).
The IRBInterH project will boost internationalisation, one of IRB Barcelona´s strategic goals. Likewise, it will also strengthen the participation of the institute in H2020, one of the key internationalization actions...
Salvador Aznar has been distinguished in the “Young Talent in Biomedical Research” category